In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates (Q33979294)

30 July 2017

title

In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8,796 clinical bacterial isolates (English)

1 reference

30 July 2017

1 reference

Milatovic D

1

1 reference

30 July 2017

Schmitz FJ

2

1 reference

30 July 2017

Brisse S

3

1 reference

30 July 2017

Verhoef J

4

1 reference

30 July 2017

Fluit AC

5

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

1102-1107

1 reference

In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rods

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

In vitro antibacterial activity of DU-6859a, a new fluoroquinolone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

In vitro activity of DU-6859a against anaerobic bacteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89825

Activity of two novel fluoroquinolones (DU-6859a and DV-7751a) tested against glycopeptide-resistant enterococcal isolates

5 July 2018

1 reference

12 December 2020

In vitro susceptibility of anaerobes to quinolones in the United States

1 reference

12 December 2020

In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria

1 reference

12 December 2020

Comparison of in vitro activities of DU-6859a and other fluoroquinolones against Japanese isolates of anaerobic bacteria

1 reference

12 December 2020

Bactericidal activity of the fluoroquinolone DU-6859a alone and in combination with other antimicrobial agents against multiresistant enterococci

1 reference

12 December 2020

In-vitro activity of clinafloxacin, trovafloxacin, and ciprofloxacin

1 reference

12 December 2020

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

12 December 2020

Interpretive criteria for susceptibility tests with DU-6859a and FK-037 tested against Haemophilus influenzae and Neisseria gonorrhoeae

1 reference

12 December 2020

10.1128/AAC.44.4.1102-1107.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference